107 related articles for article (PubMed ID: 6729398)
1. Prognostic factors for non-cleaved follicular center-cell lymphomas and immunoblastic sarcoma. A Bayesian approach.
Aine R; Kataja M; Alavaikko M
Scand J Haematol; 1984 May; 32(5):475-87. PubMed ID: 6729398
[TBL] [Abstract][Full Text] [Related]
2. The Lukes and Collins classification of non-Hodgkin's lymphomas. 2. A survival study of 301 patients.
Aine R; Alavaikko M; Kataja M
Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):251-6. PubMed ID: 7124396
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
4. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
5. The reproducibility of the Lukes-Collins classification of non-Hodgkin's lymphomas in a retrospective reclassification.
Apaja-Sarkkinen M; Alavaikko M
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):735-41. PubMed ID: 6540176
[TBL] [Abstract][Full Text] [Related]
6. The Lukes and Collins classification of non-Hodgkin's lymphomas. I. A histological reappraisal of 301 cases.
Alavaikko M; Aine R
Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):241-9. PubMed ID: 7124395
[TBL] [Abstract][Full Text] [Related]
7. Primary lymphomas of bone (so-called ("Parker and Jackson's reticulum cell sarcoma") : histological review of 75 cases according to the new classifications of non Hodgkin's lymphomas.
Dumont J; Mazabraud A
Biomedicine; 1979 Dec; 31(9-10):271-5. PubMed ID: 396945
[TBL] [Abstract][Full Text] [Related]
8. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
[TBL] [Abstract][Full Text] [Related]
9. Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases.
L'Hoste RJ; Filippa DA; Lieberman PH; Bretsky S
Cancer; 1984 Oct; 54(7):1397-406. PubMed ID: 6467161
[TBL] [Abstract][Full Text] [Related]
10. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma].
Brittinger G; Bartels H; Bremer K; Dühmke E; Gunzer U; König E; Stein H
Hamatol Bluttransfus; 1976; 18():211-23. PubMed ID: 786810
[No Abstract] [Full Text] [Related]
12. A clinicopathological study of stages I and II non-Hodgkin's lymphomata using the Lukes-Collins classification.
Butler JJ; Stryker JA; Shullenberger CC
Br J Cancer Suppl; 1975 Mar; 2():208-16. PubMed ID: 1101919
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.
Foucar K; McKenna RW; Frizzera G; Brunning RD
Cancer; 1982 Mar; 49(5):888-97. PubMed ID: 6977408
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility in morphologic classification of non-Hodgkin's lymphomas using the Lukes-Collins system. The Southeastern Cancer Study Group experience.
Whitcomb CC; Crissman JD; Flint A; Cousar JB; Collins RD; Byrne GE
Am J Clin Pathol; 1984 Oct; 82(4):383-8. PubMed ID: 6475834
[TBL] [Abstract][Full Text] [Related]
15. The cleaved cell content of non-cleaved (transformed) follicular center cell lymphomas and its clinico-pathological significance.
Aine R; Alavaikko M
Pathol Res Pract; 1985 Aug; 180(2):181-4. PubMed ID: 4059124
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of the Lukes-Collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapy.
Newcomer LN; Nerenberg MI; Cadman EC; Waldron JA; Farber LR; Bertino JR
Cancer; 1982 Aug; 50(3):439-43. PubMed ID: 7046901
[TBL] [Abstract][Full Text] [Related]
18. The impact of growth pattern on survival in non-Hodgkin's lymphomas classified according to Lukes and Collins.
Damber L; Lenner P; Lundgren E
Pathol Res Pract; 1982 Jul; 174(1-2):42-52. PubMed ID: 7134063
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
Lieberman PH; Filippa DA; Straus DJ; Thaler HT; Cirrincione C; Clarkson BD
Am J Med; 1986 Sep; 81(3):365-80. PubMed ID: 3752139
[TBL] [Abstract][Full Text] [Related]
20. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
